117 related articles for article (PubMed ID: 25813689)
1. Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer.
Daskivich TJ
Eur Urol; 2015 Jul; 68(1):59-60. PubMed ID: 25813689
[No Abstract] [Full Text] [Related]
2. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
3. Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
Akin-Akintayo OO; Jani AB; Odewole O; Tade FI; Nieh PT; Master VA; Bellamy LM; Halkar RK; Zhang C; Chen Z; Goodman MM; Schuster DM
Clin Nucl Med; 2017 Jan; 42(1):e22-e28. PubMed ID: 27749412
[TBL] [Abstract][Full Text] [Related]
4. Analysis of consultant decision-making in the management of prostate cancer.
Wilson J; Kennedy K; Ewings P; Macdonagh R
Prostate Cancer Prostatic Dis; 2008; 11(3):288-93. PubMed ID: 17968424
[TBL] [Abstract][Full Text] [Related]
5. Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
BJU Int; 2018 Feb; 121(2):209-216. PubMed ID: 28418195
[TBL] [Abstract][Full Text] [Related]
6. First prostate cancer audit calls for wider use of modern imaging techniques.
Wise J
BMJ; 2014 Nov; 349():g6723. PubMed ID: 25385433
[No Abstract] [Full Text] [Related]
7. [PREFERE - Study on the rise].
Ohlmann CH; Stöckle M; Albers P; Schmidberger H; Härter M; Kristiansen G; Martus P; Wellek S; Bussar-Maatz R; Wiegel T
Urologe A; 2016 Mar; 55(3):313-7. PubMed ID: 26908120
[TBL] [Abstract][Full Text] [Related]
8. [Cancer of the prostate: what treatment for what stage?].
Vanden Bossche M
Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894
[TBL] [Abstract][Full Text] [Related]
9. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
10. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
[TBL] [Abstract][Full Text] [Related]
11. Calculating life expectancy to inform prostate cancer screening and treatment decisions.
Hawken SR; Auffenberg GB; Miller DC; Lane BR; Cher ML; Abdollah F; Cho H; Ghani KR;
BJU Int; 2017 Jul; 120(1):9-11. PubMed ID: 28199761
[No Abstract] [Full Text] [Related]
12. Radical prostatectomy for localized prostate cancer: trying to define quality care.
Marshall CL; Chapin CA; Shapiro L; Rigberg H
Clin Perform Qual Health Care; 1993; 1(4):243-50. PubMed ID: 10135643
[No Abstract] [Full Text] [Related]
13. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
Zellweger T; Gasser T
Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
[No Abstract] [Full Text] [Related]
14. Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.
Daniels CP; Millar JL; Spelman T; Sengupta S; Evans SM
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):247-54. PubMed ID: 26548940
[TBL] [Abstract][Full Text] [Related]
15. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
[TBL] [Abstract][Full Text] [Related]
16. Life expectancy estimates as a key factor in over-treatment: the case of prostate cancer.
Delpierre C; Lamy S; Kelly-Irving M; Molinié F; Velten M; Tretarre B; Woronoff AS; Buemi A; Lapôtre-Ledoux B; Bara S; Guizard AV; Colonna M; Grosclaude P
Cancer Epidemiol; 2013 Aug; 37(4):462-8. PubMed ID: 23623489
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
Cohen SP; Jaskulsky SR
Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
[TBL] [Abstract][Full Text] [Related]
18. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.
Fleming C; Wasson JH; Albertsen PC; Barry MJ; Wennberg JE
JAMA; 1993 May; 269(20):2650-8. PubMed ID: 8487449
[TBL] [Abstract][Full Text] [Related]
19. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
20. Treatment choice and quality of care for men with localized prostate cancer.
Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
